10x Genomics, Inc. (TXG) Capital expenditures 2017–2025
10x Genomics, Inc. (TXG) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5.9MFY2025 · since FY2017: $3.8M → $5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.9M | -52.1% |
| FY2024 | $12.4M | -74.5% |
| FY2023 | $48.6M | -63.1% |
| FY2022 | $131.7M | +30.0% |
| FY2021 | $101.3M | +176.2% |
| FY2020 | $36.7M | -14.2% |
| FY2019 | $42.7M | +580.2% |
| FY2018 | $6.3M | +67.3% |
| FY2017 | $3.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice